Medical device firm raises $12.7 million in funding round

Upper extremity orthopedics innovator to use funding to finance growth initiatives.


  • By
  • | 2:08 p.m. May 14, 2019
File. A 2016 photo of a component of the  Catalyst CSR Total Shoulder System.
File. A 2016 photo of a component of the Catalyst CSR Total Shoulder System.
  • Charlotte–Lee–Collier
  • Share

NAPLES — Catalyst OrthoScience, a medical device company specializing on the upper extremity orthopedics market, has raised $12.7 million in an oversubscribed Series C-1 financing round led by River Cities Capital Funds.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content